|
FR2763849B1
(fr)
|
1997-05-28 |
2000-09-15 |
Rhone Poulenc Rorer Sa |
Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux
|
|
US20040018194A1
(en)
|
2000-11-28 |
2004-01-29 |
Francisco Joseph A. |
Recombinant anti-CD30 antibodies and uses thereof
|
|
US7244764B2
(en)
|
2003-06-23 |
2007-07-17 |
Neurochem (International) Limited |
Methods and compositions for treating amyloid-related diseases
|
|
US7611707B2
(en)
|
2004-04-29 |
2009-11-03 |
Otsuka Pharmaceutical Co., Ltd. |
Glycoprotein VI antibodies and methods thereof
|
|
WO2005111283A1
(ja)
*
|
2004-05-17 |
2005-11-24 |
Denki Kagaku Kogyo Kabushiki Kaisha |
ポリ塩化ビニル繊維及びその製造方法並びに人工毛髪
|
|
US7811563B2
(en)
|
2004-10-25 |
2010-10-12 |
Northwestern University |
Anti-addl antibodies and uses thereof
|
|
TW200636064A
(en)
|
2004-10-28 |
2006-10-16 |
Centocor Inc |
Anti-respiratory syncytial virus antibodies, antigens and uses thereof
|
|
CA2623565A1
(en)
|
2005-09-28 |
2007-04-05 |
Biovascular, Inc. |
Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
|
|
HUE034269T2
(en)
|
2005-12-29 |
2018-02-28 |
Janssen Biotech Inc |
Human anti-IL-23 antibodies, preparations, methods and applications
|
|
EP2447285A3
(en)
|
2006-05-25 |
2013-01-16 |
Momenta Pharmaceuticals, Inc. |
Low molecular weight heparin composition and uses thereof
|
|
KR20100014588A
(ko)
*
|
2007-02-27 |
2010-02-10 |
제넨테크, 인크. |
길항제 ｏｘ40 항체 및 염증성 및 자가면역 질환의 치료에서의 이의 용도
|
|
US8685400B2
(en)
|
2007-07-30 |
2014-04-01 |
University Of Miami |
Modulating inflammasome activity and inflammation in the central nervous system
|
|
WO2010003092A1
(en)
*
|
2008-07-03 |
2010-01-07 |
University Of Massachusetts |
Methods and compositions for reducing inflammation and treating inflammatory disorders
|
|
EP2145624A1
(en)
|
2008-07-18 |
2010-01-20 |
Sanofi-Aventis |
Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
|
|
EP2475380A1
(en)
|
2009-09-11 |
2012-07-18 |
Protaffin Biotechnologie AG |
Composition for treatment of cxcl8-mediated lung inflammation
|
|
US8759302B2
(en)
|
2010-03-16 |
2014-06-24 |
Teva Pharmaceutical Industries, Ltd. |
Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
|
|
SMT202000095T1
(it)
|
2010-05-14 |
2020-03-13 |
Amgen Inc |
Formulazioni di anticorpi anti-sclerostina ad alta concentrazione
|
|
IT1406201B1
(it)
|
2010-12-10 |
2014-02-14 |
Univ Degli Studi Trieste |
Biomarcatori per la diagnosi della sclerosi multipla
|
|
EP2684051B1
(en)
|
2011-03-11 |
2016-04-27 |
Roche Diagniostics GmbH |
Asc as marker for chronic obstructive pulmonary disease (copd)
|
|
WO2013049278A1
(en)
|
2011-09-30 |
2013-04-04 |
Novartis Ag |
USE OF IL-1 ß BINDING ANTIBODIES
|
|
EP2812697B1
(en)
|
2012-02-06 |
2017-03-22 |
University of Miami |
Innate immune proteins as biomarkers for cns injury
|
|
TWI480044B
(zh)
|
2012-03-16 |
2015-04-11 |
Taichung Veterans General Hospital |
A high molecular weight heparin or low molecular weight heparin for the preparation of a composition for at least two consecutive days of administration to improve the allergic constitution
|
|
US20140314746A1
(en)
*
|
2013-03-13 |
2014-10-23 |
Philadelphia Health And Education Corporation, d/b/a Drexel University College of Medicine |
Methods for treating or preventing fibrosis in subjects afflicted with scleroderma
|
|
HK1219512A1
(zh)
|
2013-05-17 |
2017-04-07 |
F. Hoffmann-La Roche Ag |
用於诊断和治疗炎性肠病的方法
|
|
JP6359013B2
(ja)
*
|
2013-07-29 |
2018-07-18 |
国立大学法人 鹿児島大学 |
１，５−ｄ−アンヒドロフルクトースを含むアポトーシス関連スペック様カード蛋白質の機能阻害薬
|
|
AU2015204558B2
(en)
|
2014-01-10 |
2020-04-30 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
|
EP3183582B1
(en)
|
2014-08-18 |
2020-02-12 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Biomarkers for diagnosis and management of neuro-immunological diseases
|
|
CN114699409A
(zh)
|
2014-10-16 |
2022-07-05 |
诺华股份有限公司 |
包含辛波莫德和拉喹莫德的用于治疗多发性硬化症的组合
|
|
US20160263183A1
(en)
|
2015-03-10 |
2016-09-15 |
Brown University |
Methods for treating lung disease
|
|
AU2016260190A1
(en)
|
2015-05-12 |
2017-11-23 |
The Regents Of The University Of California |
Peptide treatment for inflammation and fibrosis
|
|
US10195170B2
(en)
|
2015-08-17 |
2019-02-05 |
Twi Biotechnology, Inc. |
Methods for inhibiting expression of ASC, expression of NLRP3, and/or formation of NLRP3 inflammasome complex using diacerein or its analogs
|
|
KR101948048B1
(ko)
|
2016-12-08 |
2019-02-14 |
한양대학교 에리카산학협력단 |
톡소포자충 ｇｒａ７ 항원 유래 재조합 단백질을 유효성분으로 포함하는 결핵 예방 또는 치료용 약학 조성물
|
|
RU2019123160A
(ru)
*
|
2016-12-29 |
2021-01-29 |
Юниверсити Оф Майами |
Способ модуляции активности инфламмасом и воспаления в легком
|
|
US11840565B2
(en)
*
|
2016-12-29 |
2023-12-12 |
University Of Miami |
Methods and compositions for treating virus-associated inflammation
|
|
US10755739B1
(en)
|
2016-12-30 |
2020-08-25 |
John Fristrom |
Remote railway crossing programmable device and methods thereof
|
|
WO2019060516A1
(en)
|
2017-09-20 |
2019-03-28 |
University Of Miami |
METHOD FOR DETECTION OF INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS
|
|
SG11202013176VA
(en)
|
2018-07-03 |
2021-01-28 |
Univ Miami |
Compositions and methods for treating inflammasome related diseases or conditions
|